These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9808694)

  • 1. Ligand- and subtype-selective coupling of human alpha-2 adrenoceptors to Ca++ elevation in Chinese hamster ovary cells.
    Kukkonen JP; Renvaktar A; Shariatmadari R; Akerman KE
    J Pharmacol Exp Ther; 1998 Nov; 287(2):667-71. PubMed ID: 9808694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional assessment of recombinant human alpha(2)-adrenoceptor subtypes with cytosensor microphysiometry.
    Pihlavisto M; Scheinin M
    Eur J Pharmacol; 1999 Dec; 385(2-3):247-53. PubMed ID: 10607883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A).
    Corboz MR; Rivelli MA; McCormick KD; Wan Y; Shah H; Umland S; Lieber G; Jia Y; McLeod RL; Morgan C; Varty GB; Wu J; Feng KI; Boyce CW; Aslanian RG; Palamanda J; Nomeir AA; Korfmacher W; Hunter JC; Anthes JC; Hey JA
    J Pharmacol Exp Ther; 2011 Apr; 337(1):256-66. PubMed ID: 21233198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
    Piletz JE; Zhu H; Chikkala DN
    J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioisosteric phentolamine analogs as selective human alpha(2)- versus alpha(1)-adrenoceptor ligands.
    Bavadekar SA; Hong SS; Lee SI; Miller DD; Feller DR
    Eur J Pharmacol; 2008 Aug; 590(1-3):53-60. PubMed ID: 18589415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
    Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beta3-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]-ethyl]phenyl]benzenesulfonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human beta3-adrenoceptor.
    Sato M; Hutchinson DS; Evans BA; Summers RJ
    Mol Pharmacol; 2008 Nov; 74(5):1417-28. PubMed ID: 18684840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacology of adrenergic alpha(2C) receptors coupled to Ca(2+) signaling through different Galpha proteins.
    Kurko D; Bekes Z; Gere A; Baki A; Boros A; Kolok S; Bugovics G; Nagy J; Szombathelyi Z; Ignácz-Szendrei G
    Neurochem Int; 2009 Dec; 55(7):467-75. PubMed ID: 19426776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands.
    Bavadekar SA; Ma G; Mustafa SM; Moore BM; Miller DD; Feller DR
    J Pharmacol Exp Ther; 2006 Nov; 319(2):739-48. PubMed ID: 16873606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of alpha 2-adrenoceptors mediating contraction of dog saphenous vein: identity with the human alpha 2A subtype.
    MacLennan SJ; Luong LA; Jasper JR; To ZP; Eglen RM
    Br J Pharmacol; 1997 Aug; 121(8):1721-9. PubMed ID: 9283709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protean agonism at alpha2A-adrenoceptors.
    Jansson CC; Kukkonen JP; Näsman J; Huifang G; Wurster S; Virtanen R; Savola JM; Cockcroft V; Akerman KE
    Mol Pharmacol; 1998 May; 53(5):963-8. PubMed ID: 9584224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: evidence for effector pathway-dependent differential antagonism.
    Pauwels PJ; Rauly I; Wurch T
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1015-23. PubMed ID: 12649300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism.
    Pauwels PJ; Tardif S; Wurch T; Colpaert FC
    J Pharmacol Exp Ther; 2000 Feb; 292(2):654-63. PubMed ID: 10640303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist trafficking of G(i/o)-mediated alpha(2A)-adrenoceptor responses in HEL 92.1.7 cells.
    Kukkonen JP; Jansson CC; Akerman KE
    Br J Pharmacol; 2001 Apr; 132(7):1477-84. PubMed ID: 11264241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HepG2 and SK-N-MC: two human models to study alpha-2 adrenergic receptors of the alpha-2C subtype.
    Schaak S; Cayla C; Blaise R; Quinchon F; Paris H
    J Pharmacol Exp Ther; 1997 May; 281(2):983-91. PubMed ID: 9152409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of adenylyl cyclase by octopamine via a human cloned alpha 2A-adrenoceptor.
    Airriess CN; Rudling JE; Midgley JM; Evans PD
    Br J Pharmacol; 1997 Sep; 122(2):191-8. PubMed ID: 9313925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity.
    Bevan N; Butchers PR; Cousins R; Coates J; Edgar EV; Morrison V; Sheehan MJ; Reeves J; Wilson DJ
    Eur J Pharmacol; 2007 Jun; 564(1-3):219-25. PubMed ID: 17382926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of alpha 2-adrenoceptors in human and rat myometrium and differential expression during pregnancy.
    Bouet-Alard R; Mhaouty-Kodja S; Limon-Boulez I; Coudouel N; Maltier JP; Legrand C
    Br J Pharmacol; 1997 Dec; 122(8):1732-8. PubMed ID: 9422821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of agonist-specific coupling of cloned human alpha(2)-adrenoceptor subtypes.
    Rudling JE; Richardson J; Evans PD
    Br J Pharmacol; 2000 Nov; 131(5):933-41. PubMed ID: 11053214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of functional selectivity at the human α(1A)-adrenoceptor.
    Evans BA; Broxton N; Merlin J; Sato M; Hutchinson DS; Christopoulos A; Summers RJ
    Mol Pharmacol; 2011 Feb; 79(2):298-307. PubMed ID: 20978120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.